Log in to save to my catalogue

SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses

SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8956294

SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses

About this item

Full title

SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses

Publisher

England: Elsevier Ltd

Journal title

The Lancet (British edition), 2022-04, Vol.399 (10334), p.1463-1464

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

[...]we report outcome data for most patients. [...]because vaccination data for influenza viruses were not registered in the database, and since most patients were admitted before COVID-19 vaccinations were available, we were unable to establish the effect of influenza viruses or SARS-CoV-2 vaccination on outcome in monoinfected and co-infected pa...

Alternative Titles

Full title

SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8956294

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8956294

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(22)00383-X

How to access this item